Equities

R C M Technologies Inc

RCMT:NMQ

R C M Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)25.90
  • Today's Change0.86 / 3.43%
  • Shares traded100.85k
  • 1 Year change+3.97%
  • Beta0.6696
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 2 analysts offering 12 month price targets for R C M Technologies Inc have a median target of 37.00, with a high estimate of 37.00 and a low estimate of 37.00. The median estimate represents a 47.76% increase from the last price of 25.04.
High47.8%37.00
Med47.8%37.00
Low47.8%37.00

Earnings history & estimates in USD

On Nov 07, 2024, R C M Technologies Inc reported 3rd quarter 2024 earnings of 0.35 per share.
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate-3.12%
R C M Technologies Inc reported annual 2023 earnings of 1.96 per share on Mar 13, 2024.
Average growth rate+68.77%
More ▼

Revenue history & estimates in USD

RCM Technologies, Inc. had 3rd quarter 2024 revenues of 60.37m. This missed the 60.45m consensus estimate of the 2 analysts following the company. This was 10.07% below the prior year's 3rd quarter results.
Average growth rate+1.77%
RCM Technologies, Inc. had revenues for the full year 2023 of 263.24m. This was 7.53% below the prior year's results.
Average growth rate+11.59%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.